Target-dependent B7-H1 regulation contributes to clearance of central nervous sysyem infection and dampens morbidity

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5430-5438

  Phares, Timothy W ^a   Ramakrishna, Chandran ^a,d   Parra, Gabriel I ^a   Epstein, Alan ^b   Chen, Lieping ^c   Atkinson, Roscoe ^b   Stohlman, Stephen A ^a   Bergmann, Cornelia C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; B7 ANTIGEN; BETA INTERFERON RECEPTOR; GAMMA INTERFERON; APOPTOSIS REGULATORY PROTEIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PDCD1 PROTEIN, MOUSE; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATION; GLIA CELL; INTERFERON PRODUCTION; MICROGLIA; MORBIDITY; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; OLIGODENDROGLIA; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS INFECTION; TISSUE SPECIFICITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL MOTION; COMPARATIVE STUDY; DRUG ANTAGONISM; GENETICS; GLIA; IMMUNOLOGY; MORTALITY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPINAL CORD DISEASE; TRANSGENIC MOUSE; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL MOVEMENT; CORONAVIRUS INFECTIONS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MURINE HEPATITIS VIRUS; NEUROGLIA; PEPTIDES; SPINAL CORD DISEASES; VIRUS REPLICATION;

EID: 66949159493     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803557     Document Type: Article

References (62)

1. Gloor, S. M., M. Wachtel, M. F. Bolliger, H. Ishihara, R. Landmann, and K. Frei. 2001. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 36: 258-264. (Pubitemid 33020756)
2. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704. (Pubitemid 351600389)
3. Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8: 765-772. (Pubitemid 26148299)
4. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
5. Golden-Mason, L., J. Klarquist, A. S. Wahed, and H. R. Rosen. 2008. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J. Immunol. 180: 3637-3641.
6. + T lymphocytes in the liver. J. Immunol. 178: 2714-2720.
7. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545. (Pubitemid 35291652)
8. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
9. Usui, Y., Y. Okunuki, T. Hattori, T. Kezuka, H. Keino, N. Ebihara, S. Sugita, M. Usui, H. Goto, and M. Takeuchi. 2008. Functional expression of B7H1 on retinal pigment epithelial cells. Exp. Eye Res. 86: 52-59. (Pubitemid 350212878)
10. Lafon, M., F. Mergret, S. Meuth, O. Simon, M. L. Velandia-Romero, M. Lafage, L. Chen, L. Alexopoulou, R. A. Flavell, C. Prehaud, and H. Wiendl. 2008. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J. Immunol. 180: 7506-7515.
11. Lipp, M., C. Brandt, F. Dehghani, E. Kwidzinski, and I. Bechmann. 2007. PD-L1 (B7-H1) regulation in zones of axonal degeneration. Neurosci. Lett. 425: 156-161. (Pubitemid 47418360)
12. Magnus, T., B. Schreiner, T. Korn, C. Jack, H. Guo, J. Antel, I. Ifergan, L. Chen, F. Bischof, A. Bar-Or, and H. Wiendl. 2005. Microglia expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 25: 2537-2546. (Pubitemid 40365165)
13. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
14. Benedict, C. A., A. Loewendorf, Z. Garcia, B. R. Blazar, and E. M. Janssen. 2008. Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J. Immunol. 180: 4836-4847.
15. Jeong, H. Y., Y. J. Lee, S. K. Seo, S. W. Lee, S. J. Park, J. N. Lee, H. S. Sohn, S. Yao, L. Chen, and I. Choi. 2008. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J. Leukocyte Biol. 83: 755-764.
16. Sester, U., D. Presser, J. Dirks, B. C. Gärtner, H. Köhler, and M. Sester. 2008. PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 8: 1486-1497. (Pubitemid 351989503)
17. + T cell exhaustion during chronic viral infect. Immunity 27: 670-684.
18. Wong, R. M., R. R. Scotland, R. L. Lau, C. Wang, A. J. Korman, W. M. Kast, and J. S. Weber. 2007. Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. Int. Immunol. 19: 1223-1234.
19. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
20. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
21. Schreiner, B., M. Mitsdoerffer, B. C. Kieseier, L. Chen, H. P. Hartung, M. Weller, and H. Wiendl. 2004. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155: 172-182. (Pubitemid 39165790)
22. Iwai, Y., S. Terawaki, M. Ikegawa, T. Okazaki, and T. Honjo. 2003. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198: 39-50. (Pubitemid 36870184)
23. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distant stages of functional impairment. J. Virol. 77: 4911-4927.
24. Zajac, Y. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
25. Peng, G., S. Li, W. Wu, X. Tan, Y. Chen, and Z. Chen. 2008. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol. Immunol. 45: 963-970. (Pubitemid 350019503)
26. Penna, A., M. Pilli, A. Zerbini, A. Orlandini, S. Mezzadri, L. Sacchelli, G. Missale, and C. Ferrari. 2007. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 45: 588-601. (Pubitemid 46450610)
27. Radziewicz, H., C. C. Ibegbu, M. L. Fernandez, K. A. Workowski, K. Obideen, M. Wehbi, H. L. Hanson, J. P. Steinberg, D. Masopust, E. J. Wherry, et al. 2007. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81: 2545-2553. (Pubitemid 46447020)
28. Onlamoon, N., K. Rogers, A. E. Mayne, K. Pattanapanyasat, K. Mori, F. Villinger, and A. A. Ansari. 2008. Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection. Immunology 124: 277-293. (Pubitemid 351692908)
29. Wintterle, S., B. Schreiner, M. Mitsdoerffer, D. Schneider, L. Chen, R. Meyermann, M. Weller, and H. Wiendl. 2003. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 63: 7462-7467. (Pubitemid 37413489)
30. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
31. + T cells in the latently infected trigeminal ganglia. J. Immunol. 176: 1703-1711.
32. Bergmann, C. C., T. E. Lane, and S. A. Stohlman. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4: 121-132. (Pubitemid 43158155)
33. Marten, N. W., S. A. Stohlman, and C. C. Bergmann. 2001. MHV infection of the CNS: mechanism of immune-mediated control. Viral Immunol. 14: 1-18.
34. Wang, F. I., S. A. Stohlman, and J. O. Fleming. 1990. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J. Neuroimmunol. 30: 31-41.
35. Bergmann, C. C., B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. A. Stohlman. 2004. Perforin and γ interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 78: 1739-1750.
36. González, J. M., C. C. Bergmann, C. Ramakrishna, D. R. Hinton, R. Atkinson, J. Hoskin, W. B. Macklin, and S. A. Stohlman. 2006. Inhibition of interferon-γ signaling in oligodendroglia delays coronavirus clearance without altering demyelination. Am. J. Pathol. 168: 796-804.
37. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, and S. A. Stohlman. 1999. IFN-γ is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162: 1641-1647. (Pubitemid 29307040)
38. Lin, M. T., S. A. Stohlman, and D. R. Hinton. 1997. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71: 383-391. (Pubitemid 26412303)
39. Malone, K. E., S. A. Stohlman, C. Ramakrishna, W. B. Macklin, and C. C. Bergmann. 2008. Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis. Glia 56: 426-435.
40. + T cells cannot prevent central nervous system virus reactivation. J. Immunol. 176: 3062-3069.
41. + T cells during viral persistence in the central nervous system. J. Immunol. 163: 3379-3387.
42. Fuss, B., B. Mallon, T. Phan, C. Ohlemeyer, F. Kirchhoff, A. Nishiyama, and W. B. Macklin. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev. Biol. 218: 259-274. (Pubitemid 30101974)
43. Ireland, D. D., S. A. Stohlman, D. R. Hinton, R. Atkinson, and C. C. Bergmann. 2008. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 82: 300-310.
44. + T lymphocytes. Immunity 20: 327-336.
45. Hamo, L., S. A. Stohlman, M. Otto-Duessel, and C. C. Bergmann. 2007. Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis. Glia 55: 1169-1177. (Pubitemid 47204208)
46. Fleming, J. O., M. D. Trousdale, F. A. el-Zaatari, S. A. Stohlman, and L. P. Weiner. 1996. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58: 869-875.
47. Schachner, M., S. K. Kim, and R. Zehnle. 1981. Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies. Dev. Biol. 83: 328-338. (Pubitemid 11092438)
48. Foster, L. M., T. Phan, A. N. Verity, D. Bredesen, and A. T. Campagnoni. 1993. Generation and analysis of normal and shiverer temperature-sensitive immortalized cell lines exhibiting phenotypic characteristics of oligodendrocytes at several stages of differentiation. Dev. Neurosci. 15: 100-109.
49. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, K. Okumura, et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163. (Pubitemid 37238692)
50. Zuo, J., S. A. Stohlman, J. B. Hoskin, D. R. Hinton, R. Atkinson, and C. C. Bergmann. 2006. Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells. Virology 350: 206-215. (Pubitemid 43850588)
51. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
52. Marten, N. W., S. A. Stohlman, J. Zhou, and C. C. Bergmann. 2003. Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection. J. Virol. 77: 2775-2778.
53. Butte, M. J., V. Pena-Cruz, M. J. Kim, G. J. Freeman, and A. H. Sharpe. 2008. Interaction of human PD-L1 and B7-1. Mol. Immunol. 45: 3567-3572.
54. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
55. Roth-Cross, J. K., S. J. Bender, and S. R Weiss. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82: 9829-9838.
56. Zhou, H., and S. Perlman. 2007. Mouse hepatitis virus does not induce β interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 81: 568-574. (Pubitemid 46067884)
57. Ramakrishna, C., S. A. Stohlman, R. D. Atkinson, M. J. Shlomchik, and C. C. Bergmann. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J. Immunol. 168: 1204-1211. (Pubitemid 34094486)
58. Taylor, P. A., C. J. Lees, S. Fournier, J. P. Allison, A. H. Sharpe, and B. R. Blazar. 2004. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172: 34-39.
59. Sun, Z. W., Y. H. Qiu, Y. J. Shi, R. Tao, J. Chen, Y. Ge, Y. M. Hu, H. B. Ma, Q. Shi, and X. G. Zhang. 2005. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Cell. Immunol. 236: 146-153.
60. Redwine, J. M., M. J. Buchmeier, and C. F. Evans. 2001. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am. J. Pathol. 159: 1219-1224.
61. Carter, L. L., M. W. Leach, M. L. Azoitei, J. Cui, J. W. Pelker, J. Jussif, S. Benoit, G. Ireland, D. Luxenberg, G. R. Askew, et al. 2007. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182: 124-134.
62. Jun, H., S. K. Seo, H. Y. Jeong, H. M. Seo, G. Zhu, L. Chen, and I. H. Choi. 2005. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Lett. 579: 6259-6264. (Pubitemid 41546277)